NCT07067307View on ClinicalTrials.gov

Melatonin in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Breast Cancer
Interventions
DRUG

melatonin

melatonin 20 mg tablet once daily at bedtime

DRUG

Placebo

Placebo once daily at bedtime

Trial Locations (1)

35516

Mansoura University, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER